Table 1.
Authors/References | Sample size | Cancer type | Histology | Correlation between FDG uptake and PD-L1 expression | Correlation of FDG uptake with TILs (statistical assessment) |
|
---|---|---|---|---|---|---|
p-value | PD-L1 clone | |||||
Kasahara N / [8] | 167 | Lung cancer | SCC | 0.02 | E1L3N | Not significant |
Kaira K / [9] | 315 | Lung cancer | AC | 0.01 | E1L3N/28–8 | Not significant |
Takada K / [7] | 579 | Lung cancer | SCC/AC/other | < 0.001 | SP142 | NA |
Zhang M / [10] | 84 | Lung cancer | SCC | 0.035 | 28–8 | NA |
Kasahara N / [24] | 98 | Lung cancer | SCLC | 0.36 | E1L3N | Significant |
Hu B / [25] | 362 | Lung cancer | SCC/AC | 0.001 | 28–8 | NA |
Wang Y / [27] | 122 | Lung cancer | SCC/AC | 0.012 | NA | Significant |
Jiang H / [26] | 65 | Colon cancer | AC | 0.000 | 28–8 | NA |
Chen R / [15] | 63 | Bladder cancer | UC/SCC/SRC | 0.032 | NA | NA |
Zhao L / [28] | 84 | NPC | SCC | < 0.001 | SP263 | NA |
Hirakata T / [30] | 97 | Breast cancer | AC | < 0.001 | 28–8 | Significant |
Abbreviations: PD-L1 programmed death ligand-1, 18F-FDG 2-Deoxy-2-[18F] fluoro-D-glucose, TILs tumor infiltrative lymphocytes, SCC squamous cell carcinoma, AC adenocarcinoma, SCLC small cell lung cancer, UC urothelial cancer, SRC signet ring cell carcinoma, NPC nasopharyngeal carcinoma, NA not applicable